Capital Southwest just delivered a fiscal Q4 EPS beat — and yet the short position has barely budged, with borrow conditions staying persistently tight heading into the print.
The core tension here is a lending market that has been extremely constrained for weeks. Availability has been nearly exhausted — the borrow utilization rate spent most of April at or near 100%, easing only fractionally to 96% by May 12. That means almost every share available to lend is already out on loan. Cost to borrow has averaged around 9-10% over the past month, briefly touching 14.7% in mid-April before settling at 8.9% by last Tuesday. For a BDC trading in the mid-$20s, that's a meaningful friction cost for any new short position.
Against that backdrop, the short position itself has climbed steadily. Short interest hit 8.43% of free float as of May 12 — up from roughly 7.3% at the start of April, a 13.8% increase over the month. The bulk of that build happened in late April, jumping sharply around April 24, and has since stabilized just below the new high. With FINRA's fortnightly data pegging short shares at 4.97 million on the April 30 settlement date, and days-to-cover at 7.44, unwinding would take bears more than a week of average trading volume. The ORTEX short score sits at 73.9 — in the top 3rd percentile across the universe — and has been remarkably stable in that range all month, suggesting no fresh conviction either to add or to cover.
Options positioning, by contrast, looks notably calmer. The put/call ratio is 0.73, just below its 20-day average of 0.78 and close to neutral on a z-score basis. That's a sharp reversal from early April, when the PCR ran above 1.0 for two weeks straight — hitting 1.19 on April 15 — as traders loaded up on downside protection during the broader market stress. The recent pullback in the PCR implies options participants have removed their hedges, even as short sellers have kept their positions intact. The two signals are pointing in different directions.
The Street is modestly constructive. Analyst coverage is thin but tilts positive, with Raymond James and B. Riley holding buy-equivalent ratings and mean price targets in the $24-25 range — a modest premium to the current $23.78 print. UBS stays at Neutral with a $21.50 target. Note that the most recent analyst changes in the data are from late 2025, so these should be read as background rather than fresh conviction. The Q4 print itself was mixed: EPS of $0.57 beat the $0.56 estimate, but revenue of $57.8 million came in below the $61.6 million consensus. The bull case rests on CSWC's diversified middle-market lending book and consistent income generation; the bear case centers on elevated equity allocation relative to BDC peers, which injects more NII volatility, and potential credit headwinds if the macro outlook softens.
Insider activity adds a small positive nuance. CEO Michael Sarner bought 2,695 shares in late February at $21.90 — a modest $59k purchase, but notable as a direct buy rather than an option exercise. Net insider activity over the prior 90 days sits at a net +3,295 shares. The CEO also sold material blocks in June 2025 (around $327k), so the more recent buy represents a tone shift, even if the size is small. Institutionally, the register is fragmented, with Van Eck the largest disclosed holder at just 2.3% of shares. Empowered Funds added roughly 660,000 shares as of late February — by far the largest single-quarter institutional build in the register — though the exact timing relative to the price action is hard to pin down.
On valuation, CSWC trades at 1.35x book and 10.6x earnings — not obviously cheap for a BDC, but within normal range for a company with CSWC's income profile. The dividend score ranks in the 89th percentile, reflecting the stock's consistent supplemental and regular dividend payments; the most recently announced supplemental dividend of $0.06 per share is payable in June. With the ex-dividend date landing on May 15, income-focused shareholders have a near-term mechanical event to watch. Close BDC peers ARCC and PFLT both shed around 3-4% on the week versus CSWC's -2.1%, while OBDC and CGBD fell harder at -6.2% and -6.9% respectively — CSWC held relative ground in a rough week for the sector.
The setup now hinges on how the market digests the mixed Q4 print alongside the May 15 ex-dividend date: a short base near its highest level in months, borrow conditions that remain extremely tight, and options traders who have stepped back from the hedging they were doing only weeks ago.
See the live data behind this article on ORTEX.
Open CSWC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
